Cilengitide (EMD 121974): Mechanism of Action

Cilengitide (EMD 121974) MOA:Targeting αvβ3 Integrin/MAPK Pathway for Oncology Research

🎯 check Cilengitide (EMD 121974) product page

Cilengitide is a potent, selective cyclic RGD peptide and integrin αvβ3/αvβ5 antagonist. It affects FAK/Src/AKT, TGF-β1/Smad, and Ras/ERK/AKT signaling pathways by blocking integrin-mediated signaling, effectively inhibiting tumor cell adhesion, migration, and proliferation, and promoting apoptosis.

Primary Applications and Mechanism of Action